An ensemble approach to predicting the impact of vaccination on rotavirus disease in Niger. Issue 43 (13th October 2017)

• Record Type: Journal Article
• Authors: Park, Jaewoo; Goldstein, Joshua; Haran, Murali; Ferrari, Matthew
• Is Part Of: Vaccine. Volume 35:Issue 43(2017)
• Page Start: 5835
• Page End: 5841
• Publication Date: 2017-10-13
• Subjects: Rotavirus -- Vaccine -- Niger -- Susceptible-Infectious-Recovered models -- Bayesian model averaging; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2017.09.020
• Languages: English
• ISSNs: 0264-410X

Abstract

Abstract: Recently developed vaccines provide a new way of controlling rotavirus in sub-Saharan Africa. Models for the transmission dynamics of rotavirus are critical both for estimating current burden from imperfect surveillance and for assessing potential effects of vaccine intervention strategies. We examine rotavirus infection in the Maradi area in southern Niger using hospital surveillance data provided by Epicentre collected over two years. Additionally, a cluster survey of households in the region allows us to estimate the proportion of children with diarrhea who consulted at a health structure. Model fit and future projections are necessarily particular to a given model; thus, where there are competing models for the underlying epidemiology an ensemble approach can account for that uncertainty. We compare our results across several variants of Susceptible-Infectious-Recovered (SIR) compartmental models to quantify the impact of modeling assumptions on our estimates. Model-specific parameters are estimated by Bayesian inference using Markov chain Monte Carlo. We then use Bayesian model averaging to generate ensemble estimates of the current dynamics, including estimates of R 0, the burden of infection in the region, as well as the impact of vaccination on both the short-term dynamics and the long-term reduction of rotavirus incidence under varying levels of coverage. The ensemble of models predicts that the current burden of severe rotavirus disease is 2.6–3.7% of the population each year and that a 2-dose vaccine schedule achieving 70% coverage could reduce burden by 39–42%.